Plasma carnitine in HIV-associated neuropathy.
Simpson
D M
DM
Katzenstein
D
D
Haidich
B
B
Millington
D
D
Yiannoutsos
C
C
Schifitto
G
G
McArthur
J
J
D019380:Anti-HIV Agents / Q000009:adverse effects; D002331:Carnitine / Q000097:blood*; D015224:Dideoxynucleosides / Q000009:adverse effects; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D020932:Nerve Growth Factor / Q000235:genetics / Q000627:therapeutic use*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000188:drug therapy*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D020932:Nerve Growth Factor; D002331:Carnitine